YF
SYRE icon

Yu Fan’s Spyre Therapeutics SYRE Stock Holding History

Yu Fan’s Portfolio SYRE Stock Details SYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-737,000
Closed -$16.4M – 8
2024
Q1 		$16.4M Buy
+737,000
New +$21.4M 22.68% 2
2023
Q4 		– Sell
-20,592
Closed -$348K – 6
2023
Q3 		$348K Buy
20,592
+16,110
+359% +$213K 24.67% 3
2023
Q2 		$50.5K Hold
4,482
– – 3.96% 4
2023
Q1 		$32.5K Hold
4,482
– – 1.79% 4
2022
Q4 		$50.4K Hold
4,482
– – 0.68% 5
2022
Q3 		$59K Hold
4,482
– – 0.8% 6
2022
Q2 		$57K Hold
4,482
– – 0.88% 5
2022
Q1 		$258K Hold
4,482
– – 3.49% 3
2021
Q4 		$532K Hold
4,482
– – 6.17% 3
2021
Q3 		$891K Hold
4,482
– – 15.31% 2
2021
Q2 		$780K Hold
4,482
– – 8.81% 3
2021
Q1 		$887K Hold
4,482
– – 2.32% 4
2020
Q4 		$882K Buy
+4,482
New +$929K 2.56% 3

Other funds holding SYRE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Yu Fan's SYRE Position: Q2 2024 in Review

Yu Fan sold out of Spyre Therapeutics (SYRE) in Q2 2024, closing a stake of 737,000 shares — an estimated $16.4M sold.

Yu Fan first reported a position in SYRE in Q4 2020 and held it in 13 quarters. The position peaked at $16.4M in Q1 2024. 107 funds tracked by Wall St. Rank hold SYRE as of Q2 2024.

  • Yu Fan reported no remaining Spyre Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Yu Fan sold 737,000 Spyre Therapeutics shares in Q2 2024, an estimated $16.4M.
  • Yu Fan first reported a position in Spyre Therapeutics in Q4 2020 and held it in 13 quarters.
  • Yu Fan's Spyre Therapeutics position peaked at $16.4M in Q1 2024.
  • 107 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q2 2024.

Based on Yu Fan's 13F filing for Q2 2024, filed 14 Aug 2024.